145 related articles for article (PubMed ID: 8290276)
1. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase.
Wennström S; Siegbahn A; Yokote K; Arvidsson AK; Heldin CH; Mori S; Claesson-Welsh L
Oncogene; 1994 Feb; 9(2):651-60. PubMed ID: 8290276
[TBL] [Abstract][Full Text] [Related]
2. Transduction of circular membrane ruffling by the platelet-derived growth factor beta-receptor is dependent on its kinase insert.
Arvidsson AK; Heldin CH; Claesson-Welsh L
Cell Growth Differ; 1992 Dec; 3(12):881-7. PubMed ID: 1472468
[TBL] [Abstract][Full Text] [Related]
3. Involvement of phosphatidylinositide 3'-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis.
Hooshmand-Rad R; Claesson-Welsh L; Wennström S; Yokote K; Siegbahn A; Heldin CH
Exp Cell Res; 1997 Aug; 234(2):434-41. PubMed ID: 9260914
[TBL] [Abstract][Full Text] [Related]
4. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP.
Bazenet CE; Kazlauskas A
Oncogene; 1994 Feb; 9(2):517-25. PubMed ID: 8290262
[TBL] [Abstract][Full Text] [Related]
5. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF.
Lopez-Ilasaca M; Li W; Uren A; Yu JC; Kazlauskas A; Gutkind JS; Heidaran MA
Biochem Biophys Res Commun; 1997 Mar; 232(2):273-7. PubMed ID: 9125162
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.
Yokote K; Mori S; Siegbahn A; Rönnstrand L; Wernstedt C; Heldin CH; Claesson-Welsh L
J Biol Chem; 1996 Mar; 271(9):5101-11. PubMed ID: 8617789
[TBL] [Abstract][Full Text] [Related]
7. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
[TBL] [Abstract][Full Text] [Related]
8. Functional co-operation between the subunits in heterodimeric platelet-derived growth factor receptor complexes.
Emaduddin M; Ekman S; Rönnstrand L; Heldin CH
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):523-8. PubMed ID: 10417313
[TBL] [Abstract][Full Text] [Related]
9. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
[TBL] [Abstract][Full Text] [Related]
10. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.
Cossette LJ; Hoglinger O; Mou L; Shen SH
Exp Cell Res; 1996 Mar; 223(2):459-66. PubMed ID: 8601424
[TBL] [Abstract][Full Text] [Related]
11. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
[TBL] [Abstract][Full Text] [Related]
12. Effects of overexpressing wild-type and mutant PDGF receptors on translocation of GLUT4 in transfected rat adipose cells.
Quon MJ; Chen H; Lin CH; Zhou L; Ing BL; Zarnowski MJ; Klinghoffer R; Kazlauskas A; Cushman SW; Taylor SI
Biochem Biophys Res Commun; 1996 Sep; 226(3):587-94. PubMed ID: 8831662
[TBL] [Abstract][Full Text] [Related]
13. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.
Landgren E; Klint P; Yokote K; Claesson-Welsh L
Oncogene; 1998 Jul; 17(3):283-91. PubMed ID: 9690510
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice.
Kanda S; Landgren E; Ljungström M; Claesson-Welsh L
Cell Growth Differ; 1996 Mar; 7(3):383-95. PubMed ID: 8838868
[TBL] [Abstract][Full Text] [Related]
19. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta.
Kundra V; Escobedo JA; Kazlauskas A; Kim HK; Rhee SG; Williams LT; Zetter BR
Nature; 1994 Feb; 367(6462):474-6. PubMed ID: 8107807
[TBL] [Abstract][Full Text] [Related]
20. Tyr1009 and Tyr1021 in the platelet-derived growth factor beta-receptor mediate agonist triggered calcium signalling.
Ridefelt P; Siegbahn A
Anticancer Res; 1998; 18(3A):1819-25. PubMed ID: 9673410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
